Reaction
Application Site Exfoliation reporting signals
As of the last recalculation, Application Site Exfoliation appears in 4,090 FAERS reports alongside 31 co-occurring drug terms. The strongest observed disproportionality signal is MINOXIDIL FOAM 5% (WOMENS) (PRR 94.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Minoxidil Foam 5% (Womens) | 535 | 94.8 | 96.3 |
| Minoxidil | 615 | 81.8 | 83.0 |
| Tretinoin | 70 | 44.6 | 45.0 |
| Glycerin, Lidocaine | 37 | 13.6 | 13.6 |
| Docosanol | 37 | 13.0 | 13.0 |
| Crisaborole | 22 | 11.7 | 11.7 |
| Methylphenidate | 64 | 11.4 | 11.4 |
| Buprenorphine | 194 | 11.2 | 11.2 |
| Nicotine | 76 | 9.7 | 9.7 |
| Oxybutynin | 30 | 5.2 | 5.3 |
| Estradiol | 82 | 4.9 | 4.9 |
| Dapsone | 8 | 3.8 | 3.8 |
| Progesterone | 17 | 3.8 | 3.8 |
| Ketoconazole Cream, 2% | 11 | 3.8 | 3.8 |
| Ketoconazole | 12 | 3.5 | 3.5 |
| Nicotine Polacrilex | 26 | 3.5 | 3.5 |
| Ketoconazole Foam | 10 | 3.4 | 3.5 |
| Biotin | 21 | 3.4 | 3.4 |
| Testosterone | 15 | 3.3 | 3.3 |
| Triamcinolone Acetonide Ointment Usp, 0.05% | 15 | 3.3 | 3.3 |
| Rotigotine | 9 | 3.2 | 3.2 |
| Finasteride | 35 | 3.0 | 3.0 |
| Clobetasol Propionate Ointment Usp, 0.05% | 6 | 3.0 | 3.0 |
| Clobetasol Propionate | 6 | 3.0 | 3.0 |
| Estradiol Gel 0.1% | 25 | 2.8 | 2.8 |
| Estradiol Transdermal | 25 | 2.8 | 2.8 |
| Diclofenac Potassium | 4 | 1.9 | 1.9 |
| Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride And Dextrose | 3 | 1.9 | 1.9 |
| Salicylic Acid | 17 | 1.6 | 1.6 |
| Adapalene | 39 | 1.1 | 1.1 |
| Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride | 4 | 0.7 | 0.7 |